116 related articles for article (PubMed ID: 38395085)
1. Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
Moore-Palhares D; Zeng KL; Tseng CL; Chen H; Myrehaug S; Soliman H; Maralani P; Larouche J; Shakil H; Jerzak K; Ruschin M; Zhang B; Atenafu EG; Sahgal A; Detsky J
Int J Radiat Oncol Biol Phys; 2024 Feb; ():. PubMed ID: 38395085
[TBL] [Abstract][Full Text] [Related]
2. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
3. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
[TBL] [Abstract][Full Text] [Related]
4. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
[TBL] [Abstract][Full Text] [Related]
5. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT).
Dunne EM; Sahgal A; Lo SS; Bergman A; Kosztyla R; Dea N; Chang EL; Chang UK; Chao ST; Faruqi S; Ghia AJ; Redmond KJ; Soltys SG; Liu MC
Radiother Oncol; 2020 Apr; 145():21-29. PubMed ID: 31874346
[TBL] [Abstract][Full Text] [Related]
6. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
7. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
[TBL] [Abstract][Full Text] [Related]
8. Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy.
Chen X; LeCompte MC; Gui C; Huang E; Khan MA; Hu C; Sciubba DM; Kleinberg LR; Lo SL; Redmond KJ
Radiother Oncol; 2022 Aug; 173():215-222. PubMed ID: 35667571
[TBL] [Abstract][Full Text] [Related]
9. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
10. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
11. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.
Mehta N; Zavitsanos PJ; Moldovan K; Oyelese A; Fridley JS; Gokaslan Z; Kinsella TJ; Hepel JT
Adv Radiat Oncol; 2018; 3(3):245-251. PubMed ID: 30202794
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy for Spinal Metastases at the Extreme Ends of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases.
Zeng KL; Myrehaug S; Soliman H; Tseng CL; Atenafu EG; Campbell M; Faruqi S; Lee YK; Ruschin M; da Costa L; Yang V; Spears J; Heyn C; Maralani PJ; Whyne C; Yee A; Sahgal A
Neurosurgery; 2019 Nov; 85(5):605-612. PubMed ID: 30169694
[TBL] [Abstract][Full Text] [Related]
13. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.
Ratnakumaran R; van As N; Khoo V; McDonald F; Tait D; Ahmed M; Taylor H; Griffin C; Dunne EM; Tree AC
Clin Oncol (R Coll Radiol); 2023 May; 35(5):339-346. PubMed ID: 36805131
[TBL] [Abstract][Full Text] [Related]
15. Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice.
Dunne EM; Lo SS; Liu MC; Bergman A; Kosztyla R; Chang EL; Chang UK; Chao ST; Dea N; Faruqi S; Ghia AJ; Redmond KJ; Soltys SG; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):114-120. PubMed ID: 34454046
[TBL] [Abstract][Full Text] [Related]
16. 30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel Regimen.
Moore-Palhares D; Sahgal A; Zeng KL; Myrehaug S; Tseng CL; Detsky J; Chen H; Ruschin M; Atenafu EG; Wilson J; Larouche J; da Costa L; Maralani PJ; Soliman H
Neurosurgery; 2023 Oct; 93(4):813-823. PubMed ID: 37074052
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
18. Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.
Nguyen EK; Korol R; Ali S; Cumal A; Erler D; Louie AV; Nguyen TK; Poon I; Cheung P; Chu W; Soliman H; Vesprini D; Sahgal A; Chen H
Radiother Oncol; 2023 Sep; 186():109792. PubMed ID: 37414253
[TBL] [Abstract][Full Text] [Related]
19. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
[TBL] [Abstract][Full Text] [Related]
20. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
